Intracellular Phosphate Concentration Evolution During Hemodialysis by MR Spectroscopy

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

June 14, 2017

Primary Completion Date

July 29, 2017

Study Completion Date

July 29, 2017

Conditions
End-Stage Renal Disease (ESRD)
Interventions
DEVICE

Phosphorus (31P) magnetic resonance spectroscopy

Phosphorus MR spectroscopy realized using a 3-Tesla MR imaging system. A twenty-cm circular surface coil will be set to the 31P resonance frequency and placed over the leg muscle region to obtain spectroscopy acquisitions. 31P MR spectra will be acquired before, during (every 160 seconds), and 30 minutes after dialysis. 31P MR system data will be analyzed using jMRUI Software. Five different peaks will be analyzed: inorganic phosphate, phosphocreatine, α-, β-, and γ-ATP.

OTHER

Hemodialysis

Hemodialysis realized using a 5008 generator, a portable plant, a FX80 Dialyzer, a dialyzing solution with a standard electrolytes composition. The dialysis generator will be placed outside of the MRI examination room. The dialysis lines will pass through a wave guide to connect patients positioned on the bed of the MRI. A suitably trained nurse will proceed to the cannulation of the fistula, the connection of the catheter, and the monitoring of the clinical tolerance of the session.

Trial Locations (1)

69003

Service de Néphrologie Pavillon P, Hôpital E. Herriot, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03119818 - Intracellular Phosphate Concentration Evolution During Hemodialysis by MR Spectroscopy | Biotech Hunter | Biotech Hunter